serw-MX  [xml]  
 


    
 DeCS Categories

C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.079 Basal Ganglia Diseases .
C10.228.140.079.862 Parkinsonian Disorders .
C10.228.140.079.862.800 Parkinson Disease, Secondary .
C10.228.140.079.862.800.300 MPTP Poisoning .
C10.228.662 Movement Disorders .
C10.228.662.600 Parkinsonian Disorders .
C10.228.662.600.700 Parkinson Disease, Secondary .
C10.228.662.600.700.250 MPTP Poisoning .
C10.720 Neurotoxicity Syndromes .
C10.720.606 MPTP Poisoning .
C25 Chemically-Induced Disorders .
C25.723 Poisoning .
C25.723.705 Neurotoxicity Syndromes .
C25.723.705.400 MPTP Poisoning .
D02 Organic Chemicals .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.847 Polycyclic Aromatic Hydrocarbons .
D02.455.426.559.847.638 Naphthalenes .
D02.455.426.559.847.638.960 Tetrahydronaphthalenes .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.725 Pyridines .
D03.383.725.450 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine .
D03.605 Heterocyclic Compounds, Bridged-Ring .
D03.605.687 Quinuclidines .
D03.605.687.900 Solifenacin Succinate .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.531 Isoquinolines .
D03.633.100.531.820 Tetrahydroisoquinolines .
D03.633.100.531.820.594 Solifenacin Succinate .
D03.633.300 Heterocyclic Compounds, 3-Ring .
D03.633.300.046 Acridines .
D03.633.300.046.250 Aminoacridines .
D03.633.300.046.250.900 Tacrine .
D04 Polycyclic Compounds .
D04.615 Polycyclic Aromatic Hydrocarbons .
D04.615.638 Naphthalenes .
D04.615.638.960 Tetrahydronaphthalenes .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Tetrahydronaphthalenes .
Tetralins .
Partially saturated 1,2,3,4-tetrahydronaphthalene compounds. .
1.00
24115
 
Tacrine .
1,2,3,4-Tetrahydro-9-acridinamine .
1,2,3,4-Tetrahydroaminoacridine .
9-Amino-1,2,3,4-Tetrahydroacridine .
Cognex .
Romotal .
THA 10388 .
Tacrine Hydrochloride .
Tenakrin .
Tetrahydroaminoacridine .
A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. .
0.58
21615
 
Tetrahydroisoquinolines .
1,2,3,4-Tetrahydroisoquinolines .
Tetrahydro-Isoquinolines .
Tetrahydro Isoquinolines .
A group of ISOQUINOLINES in which the nitrogen containing ring is protonated. They derive from the non-enzymatic Pictet-Spengler condensation of CATECHOLAMINES with ALDEHYDES. .
0.58
23279
 
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine .
N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine .
MPTP 13965 .
A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease. .
0.45
93308
 
MPTP Poisoning .
MPTP-Induced Degeneration of the Striatum .
MPTP-Induced Parkinsonism .
Neurotoxicity Syndrome, MPTP .
Poisoning, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine .
MPTP Induced Degeneration of the Striatum .
MPTP Induced Parkinsonism .
MPTP Neurotoxicity Syndromes .
Neurotoxicity Syndromes, MPTP .
Parkinsonism, MPTP-Induced .
Poisoning, MPTP .
MPTP Neurotoxicity Syndrome .
A condition caused by the neurotoxin MPTP which causes selective destruction of nigrostriatal dopaminergic neurons. Clinical features include irreversible parkinsonian signs including rigidity and bradykinesia (PARKINSON DISEASE, SECONDARY). MPTP toxicity is also used as an animal model for the study of PARKINSON DISEASE. (Adams et al., Principles of Neurology, 6th ed, p1072; Neurology 1986 Feb;36(2):250-8) .
0.43
21502
 
Solifenacin Succinate .
2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1- azabicyclo(2.2.2)oct-3-yl ester, (R-(R*,S*))- .
Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate .
Solifenacin .
Vesicare .
YM 905 .
YM905 .
905, YM .
Succinate, Solifenacin .
A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE. .
0.41
2317